Jack Nathan Medical Corp. JNHMF
OTC PK
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -121.55% | -- | 18.10% | 21.12% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -121.55% | -- | 18.10% | 21.12% |
| Cost of Revenue | -- | -128.73% | -- | -19.99% | 13.25% |
| Gross Profit | -- | -119.68% | -- | 29.25% | 23.55% |
| SG&A Expenses | -- | -107.94% | -- | 23.09% | 29.50% |
| Depreciation & Amortization | -- | -211.78% | -- | -13.80% | 10.61% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -113.47% | -- | 14.46% | 26.33% |
| Operating Income | -- | 93.78% | -- | -2.92% | -45.50% |
| Income Before Tax | -- | 80.25% | -- | -9.87% | -14.77% |
| Income Tax Expenses | -- | -185.25% | -- | -- | -926.23% |
| Earnings from Continuing Operations | -- | 78.74% | -- | -75.96% | -6.79% |
| Earnings from Discontinued Operations | -- | -132,033.33% | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | 201.76% | -- | 206.49% | -6.78% |
| EBIT | -- | 93.78% | -- | -2.92% | -45.50% |
| EBITDA | -- | 104.77% | -- | -11.65% | -52.65% |
| EPS Basic | -- | 201.77% | -- | 205.36% | -3.53% |
| Normalized Basic EPS | -- | 82.20% | -- | -4.24% | -58.94% |
| EPS Diluted | -- | 194.11% | -- | 198.16% | -2.58% |
| Normalized Diluted EPS | -- | 86.25% | -- | 5.00% | -59.46% |
| Average Basic Shares Outstanding | -- | 0.92% | -- | 2.45% | 2.52% |
| Average Diluted Shares Outstanding | -- | 2.44% | -- | 2.98% | 2.95% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |